{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:11:36Z","timestamp":1777957896927,"version":"3.51.4"},"reference-count":51,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Ethnic differences are crucial when considering the efficacy, safety, and dose of pharmaceuticals across diverse populations. The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guideline E5 addresses the acceptability of extrapolating foreign clinical data taking ethnic factors into consideration. Sepiapterin has recently been approved for the treatment of hyperphenylalaninemia (HPA) in patients with phenylketonuria (PKU) in Europe, the USA, and multiple additional countries worldwide. To date, no clinical trials have been conducted in the Chinese or Korean populations. An ethnic sensitivity analysis identified that the breast cancer resistance protein (BCRP) c.421C&gt;A variant was the primary factor leading to ethnic differences in BH\n                    <jats:sub>4<\/jats:sub>\n                    exposures. A correlation was established and validated between the frequency of BCRP c.421C&gt;A variant in ethnic groups and the relative\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    and AUC\n                    <jats:sub>0\u201324h<\/jats:sub>\n                    of sepiapterin major active metabolite 5,6,7,8\u2010tetrahydrobiopterin (BH\n                    <jats:sub>4<\/jats:sub>\n                    ). Based on this correlation, it was predicted that compared to White, the mean BH\n                    <jats:sub>4<\/jats:sub>\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>max<\/jats:sub>\n                    and AUC\n                    <jats:sub>0\u201324h<\/jats:sub>\n                    were 1.16\u2010fold and 1.23\u2010fold higher, respectively, in Chinese subjects, and 1.12\u2010fold and 1.17\u2010fold higher, respectively, in Korean subjects. These findings, including the clinically insignificant differences in PK exposures, the comprehensive evidence of sepiapterin's efficacy and safety, the recognition of PKU as a rare disease and designation of sepiapterin as an orphan drug for treatment of PKU in EU, the USA, Japan, South Korea, and several other countries, and the urgent unmet medical need, collectively support that conducting an ethnic bridging study in Chinese and Korean populations is not warranted.\n                  <\/jats:p>","DOI":"10.1111\/cts.70549","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:53:57Z","timestamp":1776426837000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethnic Bridging of Sepiapterin in Chinese and Korean Populations Based on Predictions From Genetic Polymorphism of Breast Cancer Resistance Protein"],"prefix":"10.1111","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-7656","authenticated-orcid":false,"given":"Lan","family":"Gao","sequence":"first","affiliation":[{"name":"PTC Therapeutics, Inc.  Warren New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-3958","authenticated-orcid":false,"given":"Neil","family":"Smith","sequence":"additional","affiliation":[{"name":"PTC Therapeutics, Inc.  Warren New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-7499","authenticated-orcid":false,"given":"Ronald","family":"Kong","sequence":"additional","affiliation":[{"name":"PTC Therapeutics, Inc.  Warren New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"ICH \u201cE5 (R1) Ethnic Factors in the Acceptability of Foreign Clinical Data \u201daccessed October 7 2025 https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/ich\u2010e\u20105\u2010r1\u2010ethnic\u2010factors\u2010acceptability\u2010foreign\u2010clinical\u2010data\u2010step\u20105_en.pdf."},{"key":"e_1_2_12_3_1","unstructured":"ICH \u201cE5 Questions & Answers: Ethnic Factors in the Acceptability of Foreign Clinical Data \u201daccessed October 7 2025 https:\/\/database.ich.org\/sites\/default\/files\/E5_Q%26As__R1_Q%26As.pdf."},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.04.001"},{"key":"e_1_2_12_5_1","unstructured":"Ministry of Health Labor and Welfare (MHLW) Japan \u201cNotification No. 739 (Kyokuchou\u2010tsuuchi) and No. 672 (Kachou\u2010tsuuchi) \u201d1998."},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.70065"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010381500"},{"key":"e_1_2_12_8_1","unstructured":"NMPA (National Medical Products Administration) China \u201cTechnical Guidelines for Accepting Data from Overseas Clinical Trials of Drugs \u201daccessed October 7 2025 https:\/\/www.nmpa.gov.cn\/zhuanti\/ypqxgg\/ggzhcfg\/20180710151401465.html?type=pc&m."},{"key":"e_1_2_12_9_1","unstructured":"NMPA (National Medical Products Administration) China \u201cClinical Requirements for Drugs Approved Overseas But Not in China \u201daccessed October 7 2025 https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/ypggtg\/ypqtggtg\/20201016145016178.html."},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70257"},{"key":"e_1_2_12_11_1","unstructured":"Ministry of Health Labour and Welfare (MHLW) Japan \u201cBasic Principles for Conducting Phase 1 Studies in Japanese Prior to Initiating Multi\u2010Regional Clinical Trials Including Japan for Drugs in Which Early Clinical Development is Preceding Outside Japan \u201daccessed October 7 2025 https:\/\/www.pmda.go.jp\/files\/000266773.pdf."},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60961-0"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00267-0"},{"issue":"4","key":"e_1_2_12_14_1","first-page":"304","article-title":"Phenylketonuria: A Review of Current and Future Treatments","volume":"4","author":"Al Hafid N.","year":"2015","journal-title":"Translational Pediatrics"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2007.05.006"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.06.006"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.02.001"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01556-3"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gimo.2023.100039"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20110293"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.1363"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-024-00488-0"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17111411"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.10.056"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2026.101683"},{"key":"e_1_2_12_26_1","unstructured":"EMA \u201cSephience \u201daccessed October 7 2025 https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/sephience."},{"key":"e_1_2_12_27_1","unstructured":"FDA \u201cSephience (Sepiapterin) Oral Powder \u201daccessed October 7 2025 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/219666s000lbl.pdf."},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13166"},{"issue":"1","key":"e_1_2_12_29_1","first-page":"3","article-title":"Innovative Design and Analysis for PK\/PD Biosimilar Bridging Studies With Multiple References","volume":"24","author":"Song F.","year":"2021","journal-title":"American Association of Pharmaceutical Scientists Journal"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70050"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.70149"},{"key":"e_1_2_12_32_1","volume-title":"American Conference on Pharmacometrics","author":"Gao L.","year":"2025"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0964-0"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.04.007"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-021-01861-9"},{"issue":"5","key":"e_1_2_12_36_1","first-page":"591","article-title":"Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry","volume":"19","author":"Fanet H.","year":"2021","journal-title":"Current Neuropharmacology"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.6.1546"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.720632"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031038"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.062174"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.05.010"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.10.006"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0568-7"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.225045"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004268128"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003256065"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00430.x"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.12.013"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.31"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.231"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12987"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2026.156513"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.70549","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cts.70549","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.70549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:24:39Z","timestamp":1777955079000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.70549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/cts.70549"],"URL":"https:\/\/doi.org\/10.1111\/cts.70549","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-12-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70549"}}